PeptiSystems Strengthens Leadership in Quality Assurance and Engineering with new VP appointment

19th of February, 2025 - Uppsala, Sweden,

PeptiSystems AB announces Mårten Bergström joining the team

PeptiSystems raises 45 MSEK to accelerate growth in peptide and oligonucleotide drug manufacturing
20 December, 2024 - Uppsala, Sweden.
PeptiSystems AB informs about raising 45M SEK in the new investment round

PeptiSystems AB Signs Distributorship Agreement with Gene Company Limited
6 November, 2024 - Uppsala, Sweden.
PeptiSystems AB informs about signing the Distribution Agreement with Gene Company Limited in China

PeptiSystems AB announces strategic partnership with ATG Service
1 May, 2024 - Uppsala, Sweden.
PeptiSystems AB informs about signing the Partnership Agreement with ATG Service in the United States

PeptiSystems AB Successfully Closes Investment Round with New Directed Emission of Stocks
21 August, 2023 - Uppsala, Sweden.
PeptiSystems AB informs about successfully closing the next Investment Round with New Directed Emission of Stocks

PeptiSystems AB appoints Karin Granath as the new Chief Executive Officer.
17 August, 2023 - Uppsala, Sweden.
PeptiSystems AB appoints Karin Granath as the new Chief Executive Officer;
Co-founder and former CEO Lars Holmberg transitions to become Chief Scientific Officer

PeptiSystems finishes beta-testing project with Bachem.
14 November, 2022 - Uppsala, Sweden.
PeptiSystems completes a beta-testing project with Bachem evaluating new peptide synthesis instrument technology – PeptiPilot.

PeptiSystems collaborates with CordenPharma.
18 January, 2022 - Uppsala, Sweden. 
PeptiSystems and CordenPharma enter a collaboration agreement to test and evaluate a new generation of peptide synthesis technology.
Please see the CordenPharma press release here.

PeptiSystems launches products on the market!
20 December, 2021 - Uppsala, Sweden.
PeptiSystems launches a new generation of synthesis instruments for process development and large-scale manufacturing of peptides and oligonucleotides based on flowthrough column technology.